期刊文献+

低分子肝素诱导的血小板减少症2例并文献复习 被引量:5

下载PDF
导出
摘要 目的探讨肝素诱导的血小板减少症的诊断和治疗的临床特点。方法 2例低分子肝素诱导的血小板减少症患者,通过血细胞分析、凝血五项等检查,诊断为肝素诱导的血小板减少症。结果经给予停用低分子肝素及补充凝血因子等治疗,恢复良好。结论低肝素诱导的血小板减少症是一种少见症,临床医生应充分认识这一疾病的特点,并在临床中注意预防。
出处 《临床肺科杂志》 2012年第5期962-962,964,共2页 Journal of Clinical Pulmonary Medicine
  • 相关文献

参考文献5

二级参考文献47

  • 1[1]Menajovsky LB.Heparin-induced thrombocytopenin:clinical manifestations and management strategies[J].Am J Med,2005;118 (Suppl.8A):S21-S30.
  • 2[2]Weismann RE,Tobin RW.Arterial embolism occurring during systemic heparin therapy[J].AMA Arch Surg,1958;76:219-225.
  • 3[3]Kelton JG.The pathophysiology of heparin-induced thrombocytopenia:biological basis for treatment[J].Chest,2005;127(Supply):S9-S20.
  • 4[4]Franehini M.Heparin-induced thrombocytopenia:an update[J].Thromb J,2005;3:14-19.
  • 5[5]Lubenow N,Kempf R,Eichner A,et al.Heparin-induced thromliocytoponia:temporal pattern of thromboeytopenia in relation to initial use or reexposure to heparin[J].Chest,2002;122:37-42.
  • 6[6]Rice L,Attisha WK,Drexler A,et al.Delayed-onset heparin-induced thrombocytopenia[J].Ann Intern Med,2002;136:210-215.
  • 7[7]Liu CY,Battaglia M,Lee SH,et al.Platelet factor D differentially modulates CD4 + CD25 + (Regulatory)venus CD4 + CD25-(Nonregulatory) T cell[J].J Immuno,2005;174:2680-2686.
  • 8[8]Reilly MP,Taylor SM,Hartman NK,et al.Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet 4 and platelet activation through FcγR Ⅱ A[J].Blood,2001;98:2422-2447.
  • 9[9]Rauova L,Poncz M,MeKenzie SE,et al.Ultralarge complexs of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopania[J].Blood,2005;105:131-138.
  • 10[10]Warkentin TE,Greinacher A.Heparin-induced thrombocytopenia:Recognition,treatment,and prevention.The seventh ACCP conference on antithrombotic and thrombolytic therapy[J].Chest,2004;126(Suppl.):S311-S337.

共引文献88

同被引文献15

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部